Revilico
Los Angeles · Founded 2024
About Revilico
AI and Physics Driven Drug Discovery Platform
Company Facts
- Founded: 2024
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $245.0K
- Funding stage: Seed
- Last round: Pre-Seed (Mar 2025)
- Website: https://revilico.bio/
- Phone: Christopher.Korban@revilico.bio
Industries & Categories
Artificial Intelligence (AI), Biopharma, Biotechnology, Generative AI, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/revilico-556 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.